Institute for Advancing Medical Innovation (IAMI)

Inspired by the opportunity to grow educational and entrepreneurial capacity, the Institute for Advancing Medical Innovation (IAMI) was established upon the belief that: ideas are translated to innovation to improve health. The Institute focuses on education and research that advances medical innovation. The results ultimately accelerate the number and quality of new drugs, medical devices and drug-medical device combinations flowing from the investigators bench to the patient's bedside. Guided by an advisory board of independent experts and staffed by experienced drug development and medical device leaders, the Institute is designed to create an unprecedented collaboration of resources and processes to support the following key objectives:

  1. Translate innovative research into medical innovations, and through proof-of-concept awards to translational researchers, advance these innovations through a series of commercially-focused go/no go decision points;
  2. Advance novel new drugs, drug products, and drug delivery platform technologies to patients through effective partnerships with other academic institutions (including other CTSAs), industry, government and disease philanthropy organizations;
  3. Develop drug discovery, drug delivery, and bioengineering innovators who have the skill sets, sense of urgency and access to resources necessary to drive medical innovation discoveries from the university to the clinic through an Innovation Fellow Training Program;
  4. Operate an Office of Project and Portfolio Management that will identify projects, create project teams and timelines, and work with the KU Center for Technology Commercialization to create and enhance value proposition.